Efficacy News and Research

RSS
Neutralizing antibodies to SARS-CoV-2 in mice depend on Fc effector function

Neutralizing antibodies to SARS-CoV-2 in mice depend on Fc effector function

New covalent and non-covalent SARS-CoV-2 inhibitors discovered in silico

New covalent and non-covalent SARS-CoV-2 inhibitors discovered in silico

Delaying second doses of COVID-19 vaccines can reduce positive cases

Delaying second doses of COVID-19 vaccines can reduce positive cases

Epitope antibody testing is effective in detecting immune responses to SARS-CoV-2

Epitope antibody testing is effective in detecting immune responses to SARS-CoV-2

Study may lead to more refined approaches for head and neck cancers

Study may lead to more refined approaches for head and neck cancers

SARS-CoV-2 infection after vaccination is possible, shows study

SARS-CoV-2 infection after vaccination is possible, shows study

CureVac's COVID-19 vaccine protects mice against emerging SARS-CoV-2 variants

CureVac's COVID-19 vaccine protects mice against emerging SARS-CoV-2 variants

Correlation of antibody titers with COVID-19 vaccine efficacy

Correlation of antibody titers with COVID-19 vaccine efficacy

A new COVID-19 candidate vaccine induces robust humoral and cellular immune responses in mice

A new COVID-19 candidate vaccine induces robust humoral and cellular immune responses in mice

Study reveals new approach for treating diabetic foot ulcers

Study reveals new approach for treating diabetic foot ulcers

Dandelion extract inhibits SARS-CoV-2 in vitro

Dandelion extract inhibits SARS-CoV-2 in vitro

Study may help develop effective biosensors for non-invasive diagnosis of prostate cancer

Study may help develop effective biosensors for non-invasive diagnosis of prostate cancer

Single BNT162b2 mRNA dose induces humoral and T cell responses against mutated variants with a history of COVID-19

Single BNT162b2 mRNA dose induces humoral and T cell responses against mutated variants with a history of COVID-19

B.1.1.7 SARS-CoV-2 variant significantly more dangerous

B.1.1.7 SARS-CoV-2 variant significantly more dangerous

New treatment for late-stage neuroendocrine tumors found to be more effective and less toxic

New treatment for late-stage neuroendocrine tumors found to be more effective and less toxic

Disease-driving B cells play a role in the development of NAFLD

Disease-driving B cells play a role in the development of NAFLD

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

Sealing fistulas more effectively with water-immiscible mussel protein-based bioadhesive

Sealing fistulas more effectively with water-immiscible mussel protein-based bioadhesive

FDA warns two companies for illegal marketing of unapproved CBD products

FDA warns two companies for illegal marketing of unapproved CBD products

Researchers test novel gene regulation approach to treat brain diseases

Researchers test novel gene regulation approach to treat brain diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.